Spartan Bioscience Begins Italian Trial for CYP2C19 DNA Test
December 08, 2011
Spartan Bioscience Begins Italian Trial for CYP2C19 DNA Test
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Spartan Bioscience Gets CE IVD Mark for 'Sample-to-Answer' CYP2C19 Testing Platform
December 23, 2010 / PCR Insider - Canada's Spartan Bioscience Launches POC DNA Testing System for PGx Applications
August 12, 2010 / PCR Insider - Dx Focus: Akonni TruDiagnosis Studies; Spartan Bio CYP2C19 Test; Mitomics Prostate Cancer Assay
January 10, 2013 / PCR Insider - Canadian Trial Validates Spartan Bioscience's Point-of-Care Platform for PGx Applications
November 17, 2011 / PCR Insider - GenomeWeb Feature: Tools for Point-of-Care MDx Available, but Challenges Still Loom
February 28, 2013 / PCR Insider